The DOI matches its Crossref record.
Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis
Abstract
The relationship of a basement membrane collagen degrading enzyme (BM collagenase) and plasminogen activator (PA) was studied in a number of non‐malignant and malignant human and murine cell lines. Several non‐malignant cell lines secreted significant amounts of PA but no detectable BM collagenase activity whereas the malignant cell lines, with one exception, secreted both enzymes. Therefore, the secretion of BM collagenase appears to be a characteristic of many malignant cells whereas PA is synthesized also by normal cells. The BM collagenase needed proteolytic activation for maximal activity indicating that it is secreted in a latent form. The addition of plasminogen to the culture medium of human fibrosarcoma cells (HT‐1080) resulted in maximal activation of the enzyme. Plasmin, but not plasminogen, increased the activity of partially purified enzyme protein. Accordingly, the activation of latent BM collagenase in vivo may be facilitated by PA through the conversion of plasminogen to plasmin. It is suggested that the secretion of BM collagenase concomtantly with PA is a prerequisite for metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Matrix metalloproteinases (MMPs) in oral diseases
Sorsa, T., Tjäderhane, L., & Salo, T. (2004) · Oral Diseases · doi:10.1111/j.1601-0825.2004.01038.x · Cited by 618
Self-citationExtracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
Stetler‐Stevenson, W. G., Liotta, L. A., & Kleiner, D. E. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.8262328 · Cited by 596
Self-citationTumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Proteolytic degradation of extracellular matrix in tumor invasion
Tryggvason, K., Höyhtyä, M., & Salo, T. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90006-0 · Cited by 476
Self-citationMignatti, P., Tsuboi, R., Robbins, E., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.671 · Cited by 453
Plasminogen activation and regulation of pericellular proteolysis
Saksela, O. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90014-9 · Cited by 436
Engineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Ray, J., & Stetler-Stevenson, W. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112062 · Cited by 359
Autocrine saturation of pro-urokinase receptors on human A431 cells
Stoppelli, M. P., Tacchetti, C., Cubellis, M. V., Corti, A., Hearings, V. J., Cassani, G., Appella, E., & Blasi, F. (1986) · Cell · doi:10.1016/0092-8674(86)90782-8 · Cited by 355
Moscatelli, D., & Rifkin, D. B. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90005-4 · Cited by 352
Structural biochemistry and activation of matrix metalloproteases
Kleiner, D. E., & Stetler-Stevenson, W. G. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90040-w · Cited by 342
The Activation of Human Type IV Collagenase Proenzyme
Stetler-Stevenson, W. G., Krutzsch, H. C., Wacher, M. P., Margulies, I. M. K., & Liotta, L. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94193-1 · Cited by 333
Self-citationStructure of the human type IV collagenase gene.
Huhtala, P., Chow, L. T., & Tryggvason, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38559-x · Cited by 310
Self-citationPöllänen, J., Saksela, O., Salonen, E., Andreasen, P., Nielsen, L., Danø, K., & Vaheri, A. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.4.1085 · Cited by 292
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
Schnaper, H. W., Grant, D. S., Stetler‐Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., French, D. L., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560204 · Cited by 289
Directed Plasminogen Activation at the Surface of Normal and Malignant Cells
(1991) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61002-7 · Cited by 281
Ossowski, L. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2437 · Cited by 271
Shepherd, F. A., Giaccone, G., Seymour, L., Debruyne, C., Bezjak, A., Hirsh, V., Smylie, M., Rubin, S., Martins, H., Lamont, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.108 · Cited by 262
Laiho, M., Saksela, O., & Keski-Oja, J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45403-8 · Cited by 257
Self-citationPericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin
Lohi, J., Kesksi‐Oja, J., & Harvima, I. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500402 · Cited by 182
Metadata
- Authors
- Salo, T., Liotta, L. A., Keski‐Oja, J., Turpeenniemi‐Hujanen, T., & Tryggvason, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1982-11-15
- Volume
- 30
- Issue
- 5
- Pages
- 669-673
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2170424061
- Cited by
- 195
- References
- 0
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.